We are live on ! Find out more
NVO

Novo Nordisk
NVO

505 hedge funds and large institutions have $10.7B invested in Novo Nordisk in 2015 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 181 increasing their positions, 179 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more call options, than puts

Call options by funds: $36.4M | Put options by funds: $8.25M

78% more funds holding in top 10

Funds holding in top 10: 18 → 32 (+14)

33% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 42

25% more capital invested

Capital invested by funds: $8.56B → $10.7B (+$2.17B)

1% more funds holding

Funds holding: 500 → 505 (+5)

1% more repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 179

0.11% less ownership

Funds ownership: 19.06% → 18.96% (-0.11%)

Holders
505
Holders Change
+5
Holders Change %
+1%
% of All Funds
13.46%
Holding in Top 10
32
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+77.78%
% of All Funds
0.85%
New
56
Increased
181
Reduced
179
Closed
42
Calls
$36.4M
Puts
$8.25M
Net Calls
+$28.2M
Net Calls Change
+$28.3M

Top Buyers

1
Ameriprise
Ameriprise
Minnesota
+$181M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$60M
3
JSP
Jackson Square Partners
California
+$34.9M
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$30.3M
5
WCM Investment Management
WCM Investment Management
California
+$28M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$114M
2
O
OppenheimerFunds
New York
-$80.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$50.7M
4
TIM
Thornburg Investment Management
New Mexico
-$43.3M
5
Jennison Associates
Jennison Associates
New York
-$31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$1.25B -$31M -1,345,534 -3%
Renaissance Technologies
2
Renaissance Technologies
New York
$775M -$50.7M -2,202,000 -7%
Fisher Asset Management
3
Fisher Asset Management
Washington
$676M -$17.5M -758,826 -3%
JSP
4
Jackson Square Partners
California
$619M +$34.9M +1,515,594 +7%
Bank of America
5
Bank of America
North Carolina
$512M -$11.4M -495,246 -3%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$502M +$2.59M +112,476 +0.6%
Loomis, Sayles & Company
7
Loomis, Sayles & Company
Massachusetts
$422M +$60M +2,604,328 +20%
Fayez Sarofim & Co
8
Fayez Sarofim & Co
Texas
$359M +$2.02M +87,566 +0.7%
F
9
Folketrygdfondet
Norway
$352M +$4.62M +200,468 +2%
Ameriprise
10
Ameriprise
Minnesota
$270M +$181M +7,845,902 +357%
WCM Investment Management
11
WCM Investment Management
California
$249M +$28M +1,216,220 +15%
MAA
12
Managed Account Advisors
New Jersey
$237M +$25M +1,086,032 +14%
Macquarie Group
13
Macquarie Group
Australia
$214M +$16.4M +713,060 +10%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$196M -$364K -15,800 -0.2%
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$186M -$114M -4,931,578 -41%
EHC
16
Everett Harris & Co
California
$167M +$104K +4,520 +0.1%
State Farm Mutual Automobile Insurance
17
State Farm Mutual Automobile Insurance
Illinois
$158M – – –
DAC
18
Dividend Assets Capital
South Carolina
$148M +$4.94M +214,556 +4%
HL
19
Harding Loevner
New Jersey
$139M +$9.07M +393,872 +8%
Northern Trust
20
Northern Trust
Illinois
$136M +$17M +739,096 +17%
Lazard Asset Management
21
Lazard Asset Management
New York
$107M -$288K -12,504 -0.3%
Capital International Investors
22
Capital International Investors
California
$107M – – –
SBAM
23
Santa Barbara Asset Management
California
$103M +$1.88M +81,814 +2%
EVM
24
Eaton Vance Management
Massachusetts
$95.2M -$256K -11,138 -0.3%
LWCFA
25
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$93.6M -$397K -17,224 -0.5%
1
2 3 4 5

NVO Hedge Fund Activity: Q1 2015 in Review

505 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2015, worth a combined $10.7B — up 25% from $8.56B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new NVO positions and 42 closed out — a net gain of 14 holders — while 181 added to existing stakes and 179 trimmed.

The largest buyer was Ameriprise, adding an estimated $181M. The largest seller was Arrowstreet Capital, cutting an estimated $114M.

  • 505 institutional investors held Novo Nordisk (NVO) as of Q1 2015, up from 500 in Q4 2014.
  • Funds reported $10.7B of Novo Nordisk stock for Q1 2015, up 25% quarter-over-quarter.
  • 56 funds opened new Novo Nordisk positions in Q1 2015 and 42 closed out, a net change of +14 holders.
  • The largest Novo Nordisk buyer in Q1 2015 was Ameriprise, an estimated $181M added.
  • The largest Novo Nordisk seller in Q1 2015 was Arrowstreet Capital, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2015.